NEWS & UPDATES Phil Ball 12/19/24 Phil Ball 12/19/24 Tolerance Bio, Inc. Announces Scientific Advisory Board and Completion of $20.2 Million Seed Round to Advance Thymus-Based Therapies for Immune-Mediated Diseases Read More Phil Ball 10/15/24 Phil Ball 10/15/24 Tolerance Bio, Inc. Launches with $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases Read More
Phil Ball 12/19/24 Phil Ball 12/19/24 Tolerance Bio, Inc. Announces Scientific Advisory Board and Completion of $20.2 Million Seed Round to Advance Thymus-Based Therapies for Immune-Mediated Diseases Read More
Phil Ball 10/15/24 Phil Ball 10/15/24 Tolerance Bio, Inc. Launches with $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases Read More
